GLP-1(7-36)-amide and exendin-4 stimulate the HPA axis in rodents and humans

Endocrinology

Volumn 151, Issue 6, 2010, Pages 2629-2640

  Gil Lozano, Manuel ^a   Pérez Tilve, Diego ^a,c   Alvarez Crespo, Mayte ^a   Martís, Aurelio ^b   Fernandez, Ana M ^d   Catalina, Pablo A F ^b   Gonzalez Matias, Lucas C ^a   Mallo, Federico ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b HOSPITAL MONTECELO   (Spain)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d INSTITUTO CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOSTERONE; CORTICOTROPIN; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCOSE; HYDROCORTISONE; INSULIN; SOMATOMEDIN C RECEPTOR; GLUCAGON LIKE PEPTIDE 1; PEPTIDE; VENOM;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONSCIOUSNESS; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN LIKE ACTIVITY; INSULIN TREATMENT; MALE; MOUSE; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; STRESS; TRANSGENIC MOUSE; ANIMAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; SPRAGUE DAWLEY RAT;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANIMALS; CORTICOSTERONE; DIABETES MELLITUS, TYPE 1; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, TRANSGENIC; PEPTIDES; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; VENOMS; YOUNG ADULT;

EID: 77954531416     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0915     Document Type: Article

References (40)

1. Kieffer TJ, Habener JF 1999 The glucagon-like peptides. Endocr Rev 20:876-913
2. Holst JJ 2007 The physiology of glucagon-like peptide-1. Physiol Rev 87:1409-1439
3. Drucker DJ 2003 Glucagon-like peptide-1 and the islet β-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144:5145-5248
4. Kreymann B, Ghatei MA, Burnet P, Williams G, Kanse S, Diani AR, Bloom SR 1989 Characterization of glucagon-like peptide I (7-36) amide in the hypothalamus. Brain Res 502:325-331
5. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR 1996 A role for glucagon-like peptide 1 in the central regulation of feeding. Nature 379:69-72 (Pubitemid 26008136)
6. Barragán JM, Eng J, Rodríguez R, Blázquez E 1999 Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. Am J Physiol 277(5 Pt 1):E784-E791
7. Shughrue PJ, Lane MV, Merchenthaler I 1996 Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 137:5159-5162
8. Beak SA, Heath MM, Small CJ, Morgan DG, Ghatei MA, Taylor AD, Buckingham JC, Bloom SR, Smith DM 1998 Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. J Clin Invest 101:1334-1341
9. Beak SA, Small CJ, Ilovaiskaia I, Hurley JD, Ghatei MA, Bloom SR, Smith DM 1996 Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on α-TSH cells. Endocrinology 137:4130-4138
10. Kinzig KP, D'Alessio DA, Herman JP, Sakai RR, Vahl TP, Figueiredo HF, Murphy EK, Seeley RJ 2003 CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. J Neurosci 23:6163-6170
11. Larsen PJ, Tang-Christensen M, Jessop DS 1997 Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 138:4444-4455
12. Bojanowska E, Stempniak B 2000 Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat. Regul Peptides 91:75-81
13. Thorens B, Porret A, Bühler L, Deng SP, Morel P, Widmann C 1993 Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes 42:1678-1682
14. Drucker DJ, Nauck MA 2006 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696-1705
15. Nishizawa M, Nakabayashi H, Kawai K, Ito T, Kawakami S, Nakagawa A, Niijima A, Uchida K 2000 The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor. J Autonom Nerv Syst 80:14-21
16. Yang H, Egan JM, Wang Y, Moyes CD, Roth J, Montrose MH, Montrose-Rafizadeh C 1998 GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor. Am J Physiol 44:C675-C683
17. Luque M, González N, Márquez L, Acitores A, Redondo A, Morales M, Valverde I, Villanueva-Peñacarrillo ML 2002 Glucagon-like peptide-1 (GLP-1) and glucose meabolism in human myocytes. J Endocrinol 173:465-473
18. Montrose-Rafizadeh C, Yang H, Wang Y, Roth J, Montrose MH, Adams LG 1997 Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. J Cell Physiol 172:275-283
19. Pérez-Tilve D, González-Matías L, Alvarez-Crespo M, Leiras R, Tovar S, Diéguez C, Mallo F 2007 Exendin-4 potently decreases ghrelin levels in fasting rats. Diabetes 56:143-151
20. Rinaman L 1999 Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. Am J Physiol 277(2 Pt 2):R582-R590
21. Fernández AM, Kim JK, Yakar S, Dupont J, Hernandez-Sanchez C, Castle AL, Filmore J, Shulman GI, Le Roith D 2001 Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Gene Dev 15:1926-1934
22. Paxinos G, Watson C 1998 The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press; 22
23. Kastin AJ, Akerstrom V, Pan W 2002 Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci 18:7-14
24. Imeryüz N, Yegen ÇB, Bozkurt A, Coskun T, Villanueva-Peñacarrillo ML, Ulusoy NB 1997 Glucagon-like peptide 1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol 273:920-927
25. Alvarez E, Roncero I, Chowen JA, Thorens B, Blázquez E 1996 Expression of the glucagon-like peptide-1 receptor gene in rat brain. J Neurochem 66:920-927
26. Dunphy JL, Taylor RG, Fuller PJ 1998 Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. M Cell Endocrinol 141:179-186
27. Andreis PG, Malendowicz LK, Neri G, Tortorella C, Nussdorfer GG 1999 Effects of glucagon and glucagon-like peptide 1 on glucocorticoid secretion of dispersed rat adrenocortical cells. Life Sci 64:2187-2197 (Pubitemid 29254038)
28. Yamamoto H, Kishi T, Lee CE, Choi BJ, Fang H, Hollenberg AN, Drucker DJ, Elmquist JK 2003 Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J Neurosci 23:2939-2946
29. Gardiner SM, March JE, Kemp PA, Bennett T 2006 Mesenteric vasoconstriction and hindquarters vasodilatation accompany the pressor actions of exendin-4 in conscious rats. J Pharmacol Exp Ther 316:852-859
30. Ulrich-Lai YM, Arnhold MM, Engeland WC 2005 Adrenal splanchnic innervation contributes to the diurnal rhythm of plasma corticosterone in rats by modulating adrenal sensitivity to ACTH. Am J Physiol-Reg-I 290:R1128-R1135
31. Simonsen L, Holst JJ, Deacon CF 2006 Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs. Diabetologia 49:706-712
32. Kieffer TJ, McIntosh CH, Pederson RA 1995 Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide-1 in vitro and in vivo by dipeptidil peptidase IV. Endocrinology 136:3585-3596
33. Malendowicz LK, Neri G, Nussdorfer GG, Nowak KW, Zyterska A, Ziolkowska A 2003 Prolonged exendin-4 administration stimulates pituitary-adrenocortical axis of normal and streptozotocininduced diabetic rats. Int J Mol Med 12:593-596
34. Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hüfner M, Schmiegel WH 2002 Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycaemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab 87:1239-1246
35. Yamada F, Inoue S, Saitoh T, Tanaka K, Satoh S, Takamura Y 1993 Glucoregulatory hormones in the inmobilization stress-induced increase of plasma glucose in fasted and fed rats. Endocrinology 132:2199-2205
36. Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C, Obradovic S, Dieguez C, Casanueva FF 2000 GH-releasing hormona and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 356:1137-1142
37. Pekic S, Doknic M, Miljic D, Joksimovic M, Glodic J, Djurovic M, Dieguez C, Casanueva F, Popovic V 2006 Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly. Eur J Endocrinol 154:659-666
38. Reimondo G, Paccotti P, Minetto M, Termine A, Stura G, Bergui M, Angeli A, Terzolo M 2003 The corticotrophin-releasing hormone test is the most reliable non-invasive method to differenciate pituitary from ectopic ACTH secretion in Cushing's syndrome. Clin Endocrinol 58:718-724
39. van Tijn DA, de Vijlder JJ, Vulsma T 2008 Role of the thyrotrophinreleasing hormone stimulation test in diagnosis of congenital central hypothyroidism in infants. J Clin Endocrinol Metab 93:410-419
40. Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA 2002 Lack of effect of exendin 4 and glucagon-like peptide1(7-36)-amideoninsulin action in non-diabetic humans. Diabetologia 45:1410-1415